From hype to impact: how to integrate AI into pharmaceutical social media

Published: 8 July 2026

Author(s): Beth Gaffey

Following the Pharma Social Media Conference 2026, one theme became clear:

AI, digital innovation and social media are no longer “future topics” for pharmaceutical companies, they are operational realities.

However, as AI itself dominates headlines, the most compelling discussions within our industry are focused on how to use these tools responsibly, effectively, and with real human input and value.

Across case studies and panel discussions, a consistent message became clear: the business problems and needs must come before the technology.

AI is not powerful because it exists. It is powerful when it solves a specific need- meaning without a clear link to real business challenges, there is a risk of investing in solutions that deliver limited impact.

This blog explores what that looks like in practice, drawing on key learnings from the Pharma Social Media conference 2026 to demonstrate how organisations can move from experimentation to meaningful, scalable impact.